NEW YORK (GenomeWeb) – Inova recently announced a $50 million gift from Dwight Schar to launch a new oncology research institute at the Inova Center for Personalized Health in Fairfax, Virginia.

The gift will establish the Dwight and Martha Schar Cancer Institute to develop and apply genomic personalized medicine in cancer treatment.

Donald "Skip" Trump will lead the cancer institute as CEO and executive director, Inova said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.